ArticleBiomedicines2026

Risk of Mortality and Cardiovascular Events in Patients with Chronic Obstructive Pulmonary Disease Treated with Azithromycin, Roxithromycin, Clarithromycin and Amoxicillin in Primary and Secondary Care.

Imane Achir Alispahic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.